CCS
MDLN icon

Concentric Capital Strategies’s Medline Inc MDLN Stock Holding History

Concentric Capital Strategies’s Portfolio MDLN Stock Details MDLN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-30,186
Closed -$1.27M – 419
2025
Q4 		$1.27M Buy
+30,186
New +$1.27M 0.06% 194

Other funds holding MDLN

Carlyle Group
Carlyle Group Washington, District of Columbia $10B AUM 10.61% 1-Year Est. Return
Blackstone Inc
Blackstone Inc New York $39B AUM 18.55% 1-Year Est. Return
HFCIX
H&F Corporate Investors X San Francisco, California $2.8B AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Concentric Capital Strategies's MDLN Position: Q1 2026 in Review

Concentric Capital Strategies sold out of Medline Inc (MDLN) in Q1 2026, closing a stake of 30,186 shares — an estimated $1.27M sold.

Concentric Capital Strategies first reported a position in MDLN in Q4 2025 and held it in 1 quarter. The position peaked at $1.27M in Q4 2025. 315 funds tracked by Wall St. Rank hold MDLN as of Q1 2026.

  • Concentric Capital Strategies reported no remaining Medline Inc position as of Q1 2026 after selling out during the quarter.
  • Concentric Capital Strategies sold 30,186 Medline Inc shares in Q1 2026, an estimated $1.27M.
  • Concentric Capital Strategies first reported a position in Medline Inc in Q4 2025 and held it in 1 quarter.
  • Concentric Capital Strategies's Medline Inc position peaked at $1.27M in Q4 2025.
  • 315 funds tracked by Wall St. Rank held Medline Inc as of Q1 2026.

Based on Concentric Capital Strategies's 13F filing for Q1 2026, filed 15 May 2026.